Neuraxis, INC (NRXS)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

4 annual periodsNewest to oldest
2025202420232022
Revenue$3.6M$2.7M$2.5M$2.7M
Gross profit$3.0M$2.3M$2.2M$2.4M
Research & development$493,611$433,614$169,315$225,610
Operating income−$7.8M−$7.2M−$6.7M−$3.4M
EBITDAderived−$7.8M−$7.1M−$6.6M−$3.3M
Net income−$7.8M−$8.2M−$14.6M−$4.8M
Basic EPSper diluted share-$0.95-$1.22-$4.50-$2.77
Diluted EPSper diluted share-$0.95-$1.22-$4.50-$2.77

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys8$2.25M disclosed value
Sells (SEC code S)2$1.85M disclosed value
10 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Apr 1, 2026Form 4Henrichs Timothy RobertChief Financial OfficerBuyCommon Stock7.6K$1.96$14.9K7.6K
Apr 1, 2026Form 4Carrico Thomas JoesephCRO, CCO, CPOBuyCommon Stock667$1.96$1.3K331.9K
Apr 1, 2026Form 4Carrico Brian AllenChief Executive OfficerBuyCommon Stock8.1K$1.96$15.8K348.2K
Feb 12, 2026Form 4Hannasch BrianTenPercentOwnerBuyCommon Stock40.0K$4.92$196.8K1.21M
Feb 11, 2026Form 4Hannasch BrianTenPercentOwnerBuyCommon Stock40.0K$4.65$186.0K1.17M